Next |
home / stock / amrn / amrn message board
Subject | By | Source | When |
---|---|---|---|
Thanks Laurent for all that DD | rosemountbomber | investorshub | 03/15/2025 8:43:18 PM |
Could, regarding exclusivity protection till 2039, it's not | Laurent Maldague | investorshub | 03/15/2025 4:49:30 PM |
Could, of course as far as the EU | rosemountbomber | investorshub | 03/15/2025 2:51:29 PM |
Most disturbing are the pathetic sales numbers out | couldbebetter | investorshub | 03/15/2025 11:23:16 AM |
Thanks will do. | Bullrunner2 | investorshub | 03/15/2025 10:56:04 AM |
North, No. Hikma is still using invalidity as | Number sleven | investorshub | 03/15/2025 9:30:27 AM |
That's the other shoe that will drop just | CaptBeer | investorshub | 03/15/2025 7:47:28 AM |
A settlement is not a rational strategy. | Tatsumaki | investorshub | 03/15/2025 3:31:59 AM |
I don't know DMC? We seen our share | Nukemtiltheyglow | investorshub | 03/15/2025 1:20:21 AM |
Did Hikma drop its patent invalidity contentions, or | north40000 | investorshub | 03/15/2025 12:58:31 AM |
RMB, The initial ruling would be a binding | Number sleven | investorshub | 03/15/2025 12:00:52 AM |
I follow that all along, but consider that | rosemountbomber | investorshub | 03/14/2025 11:55:42 PM |
RMB, I don't think you understand what I'm | Number sleven | investorshub | 03/14/2025 11:03:28 PM |
https://www.ncpe.ie/icosapent-ethyl-vazkepa/ | Number sleven | investorshub | 03/14/2025 10:49:32 PM |
Sure Sleven, but doesn't change the time element | rosemountbomber | investorshub | 03/14/2025 10:48:58 PM |
RMB, Read the circuit court ruling in GSK | Number sleven | investorshub | 03/14/2025 10:36:52 PM |
https://stocktwits.com/SanDiegoLiving/message/608136580 | DMC8 | investorshub | 03/14/2025 9:25:49 PM |
So true. Absent a settlement in those cases | rosemountbomber | investorshub | 03/14/2025 9:23:50 PM |
So, the missing puzzle pieces looks like the | Nukemtiltheyglow | investorshub | 03/14/2025 9:13:46 PM |
They would have been delisted if not for | seve333 | investorshub | 03/14/2025 7:20:30 PM |
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
-2.44% G/L:
$0.4138 Last:
1,455,538 Volume:
$0.42 Open:
$0.4138 Close:
Amarin Corporation plc Website:
2025-03-12 12:45:20 ET Image source: The Motley Fool. Amarin Plc (NASDAQ: AMRN) Q4 2024 Earnings Call Mar 12, 2025 , 8:00 a.m. ET Operator Continue reading
DUBLIN and BRIDGEWATER, N.J., March 12, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), today announced its intent to effect a ratio change on its American Depositary Shares (“ADS”) from one (1) ADS representing one (1) ordinary share, to the new ratio of one (1) ADS...
Portage Biotech Inc. (PRTG) is expected to report for Q3 2025 Aimei Health Technology Co. Ltd (AFJK) is expected to report for quarter end 2024-12-31 Generation Bio Co. (GBIO) is expected to report $-0.28 for Q4 2024 TAT Technologies Ltd. (TATT) is expected to report for quarter end 2...